Healthcare provider profile · identity verified

Todd A Gallman, MD

Family Practice · GREENWOOD, SC · NPI 1962498998

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	560	138
Amlodipine Besylate	Amlodipine Besylate	519	143
Lisinopril	Lisinopril	438	110
Metoprolol Succinate	Metoprolol Succinate	322	83
Levothyroxine Sodium	Levothyroxine Sodium	309	70
Metformin Hcl Er	Metformin Hcl	244	57
Valsartan	Valsartan	241	65
Pravastatin Sodium	Pravastatin Sodium	223	56
Omeprazole	Omeprazole	214	52
Pioglitazone Hcl	Pioglitazone Hcl	180	48
Duloxetine Hcl	Duloxetine Hcl	174	43
Montelukast Sodium	Montelukast Sodium	166	44
Fluticasone Propionate	Fluticasone Propionate	162	68
Escitalopram Oxalate	Escitalopram Oxalate	159	41
Gabapentin	Gabapentin	159	46
Prednisone	Prednisone	159	119
Pantoprazole Sodium	Pantoprazole Sodium	154	39
Simvastatin	Simvastatin	130	39
Zolpidem Tartrate	Zolpidem Tartrate	129	26
Trazodone Hcl	Trazodone Hcl	117	26
Hydrochlorothiazide	Hydrochlorothiazide	115	36
Tramadol Hcl	Tramadol Hcl	115	34
Losartan Potassium	Losartan Potassium	111	32
Irbesartan	Irbesartan	110	29
Ozempic	Semaglutide	101	20
Famotidine	Famotidine	99	30
Metformin Hcl	Metformin Hcl	99	25
Trulicity	Dulaglutide	94	12
Lansoprazole	Lansoprazole	91	30
Furosemide	Furosemide	89	30
Potassium Chloride	Potassium Chloride	88	28
Allopurinol	Allopurinol	87	24
Buspirone Hcl	Buspirone Hcl	79	24
Doxazosin Mesylate	Doxazosin Mesylate	78	23
Albuterol Sulfate Hfa	Albuterol Sulfate	72	39
Bupropion Xl	Bupropion Hcl	70	16
Jardiance	Empagliflozin	69	14
Carvedilol	Carvedilol	66	15
Eliquis	Apixaban	64	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	64	19
Glipizide Er	Glipizide	63	16
Clopidogrel	Clopidogrel Bisulfate	61	17
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	59	21
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	56	53
Metoprolol Tartrate	Metoprolol Tartrate	54	14
Nebivolol Hcl	Nebivolol Hcl	53	11
Pregabalin	Pregabalin	53	16
Verapamil Er	Verapamil Hcl	52	15
Triamcinolone Acetonide	Triamcinolone Acetonide	51	28
Donepezil Hcl	Donepezil Hcl	48	13
Olmesartan Medoxomil	Olmesartan Medoxomil	47	13
Ibandronate Sodium	Ibandronate Sodium	44	17
Sertraline Hcl	Sertraline Hcl	43	12
Risperidone	Risperidone	42	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	41	17
Clonidine Hcl	Clonidine Hcl	40	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	39	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	38	24
Doxycycline Hyclate	Doxycycline Hyclate	37	36
Esomeprazole Magnesium	Esomeprazole Magnesium	37	11
Fluoxetine Hcl	Fluoxetine Hcl	37	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	37	12
Sulindac	Sulindac	35	30
Atenolol	Atenolol	34	suppressed
Hydralazine Hcl	Hydralazine Hcl	33	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	32	suppressed
Colchicine	Colchicine	31	11
Ropinirole Hcl	Ropinirole Hcl	30	suppressed
Memantine Hcl	Memantine Hcl	29	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	28	25
Fluconazole	Fluconazole	27	20
Venlafaxine Hcl Er	Venlafaxine Hcl	27	suppressed
Citalopram Hbr	Citalopram Hydrobromide	26	suppressed
Diclofenac Sodium	Diclofenac Sodium	26	12
Synthroid	Levothyroxine Sodium	26	suppressed
Warfarin Sodium	Warfarin Sodium	26	suppressed
Breo Ellipta	Fluticasone/Vilanterol	25	suppressed
Sildenafil Citrate	Sildenafil Citrate	25	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	25	suppressed
Clonazepam	Clonazepam	24	suppressed
Ketoconazole	Ketoconazole	23	suppressed
Meclizine Hcl	Meclizine Hcl	23	suppressed
Phenobarbital	Phenobarbital	23	suppressed
Farxiga	Dapagliflozin Propanediol	22	suppressed
Cephalexin	Cephalexin	21	17
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	21	suppressed
Spironolactone	Spironolactone	20	suppressed
Baclofen	Baclofen	19	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	19	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	18	suppressed
Lovastatin	Lovastatin	18	suppressed
Celecoxib	Celecoxib	16	suppressed
Ondansetron Hcl	Ondansetron Hcl	16	15
Benazepril Hcl	Benazepril Hcl	15	suppressed
Glipizide	Glipizide	15	suppressed
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	suppressed
Incruse Ellipta	Umeclidinium Bromide	14	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	14	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	11
Oxycodone Hcl	Oxycodone Hcl	14	suppressed
Telmisartan	Telmisartan	14	suppressed
Terazosin Hcl	Terazosin Hcl	14	suppressed
Tizanidine Hcl	Tizanidine Hcl	14	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	14	suppressed
Cefdinir	Cefdinir	13	suppressed
Clobetasol Propionate	Clobetasol Propionate	13	suppressed
Diazepam	Diazepam	13	suppressed
Ezetimibe	Ezetimibe	13	suppressed
Levemir Flexpen	Insulin Detemir	13	suppressed
Amiodarone Hcl	Amiodarone Hcl	12	suppressed
Haloperidol	Haloperidol	12	suppressed
Klor-Con M20	Potassium Chloride	12	suppressed
Metronidazole	Metronidazole	12	suppressed
Niacin Er	Niacin	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Propranolol Hcl Er	Propranolol Hcl	12	suppressed
Carbamazepine	Carbamazepine	11	suppressed
Dexlansoprazole Dr	Dexlansoprazole	11	suppressed
Lorazepam	Lorazepam	11	suppressed
Meloxicam	Meloxicam	11	suppressed
Scopolamine	Scopolamine	11	suppressed
Vienva	Levonorgestrel/Ethin.Estradiol	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error